Is Endo International (ENDP) A Great Long-Term Investment?

Miller Value Partners, an investment management firm, published its “Miller Deep Value Strategy” fourth quarter 2021 investor letter – a copy of which can be seen here. For the fourth quarter, the Deep Value Strategy was down 8.3%, significantly more than the overall market and the S&P 1500 Value Index. For the year, the Deep Value Strategy was up 57.8%, well ahead of the Value Index and the overall market. 2021 marks the 3rd year in a row that the Strategy has generated investment returns greater than 50%. Spare some time to check the fund’s top 5 holdings to have a clue about their top bets for 2022.

Miller Value Partners Deep Value Strategy, in its Q4 2021 investor letter, mentioned Endo International plc (NASDAQ: ENDP) and discussed its stance on the firm. Endo International plc is a Dublin, Ireland-based pharmaceutical company with a $745.4 million market capitalization. ENDP delivered a -15.16% return since the beginning of the year, while its 12-month returns are down by -63.16%. The stock closed at $3.19 per share on February 2, 2022.

Here is what Miller Value Partners Deep Value Strategy has to say about Endo International plc in its Q4 2021 investor letter:

“During the quarter, we had two main positive contributors, (which includes) Endo International (ENDP), where both holdings were up more than 10%. Endo International continues to execute well on its transformation plan to become a leading specialty pharma company. We believe the company’s branded/sterile injectable portfolio will drive future revenue growth and margin expansion over the next couple of years, and management will continue to successfully optimize the company’s cost structure. While ongoing challenges remain, we believe the risks of opioid litigation and the likely upcoming generic launches against their Vasotec product, are well known and appear to be significantly over-discounted in the company’s current share price.”

Pressmaster/Shutterstock.com

Our calculations show that Endo International plc (NASDAQ: ENDP) failed to obtain a mark on our list of the 30 Most Popular Stocks Among Hedge Funds. ENDP was in 21 hedge fund portfolios at the end of the third quarter of 2021, compared to 20 funds in the previous quarter. Endo International plc (NASDAQ: ENDP) delivered a -36.58% return in the past 3 months.

In November 2021, we also shared another hedge fund’s views on ENDP in another article. You can find other letters from hedge funds and prominent investors on our hedge fund investor letters 2021 Q4 page.

Disclosure: None. This article is originally published at Insider Monkey.